Earlier, pharma companies largely relied on time-consuming and expensive methods of drug discovery. The advent of AI changed this. AI now supports research to achieve breakthroughs. It helps in manufacturing and testing novel therapies. Merck has developed an in-house clone of ChatGPT called myGPT with 30000 users. It has been used for automation and efficiency in day-to-day activities, e.g. content writing, translation, content revision, coding assistance and so on.
Merck also uses SYNTHIA, an AI-powered drug discovery platform. It also uses ADDISON, first AI-powered software-as-a-service platform that facilitates screening of billions of molecules. It accelerates the process of drug discovery and reduces its cost.
Leave a Reply